Kaken Pharmaceutical Co., Ltd. (KKPCF)

USD 24.01

(0.0%)

Annual Cash Flows

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow 17.02 Million 69.64 Million 109.55 Million 130.13 Million 254.43 Million 190.89 Million
Net Income 53.02 Million 40.94 Million 78.44 Million 121.31 Million 179.42 Million 160.59 Million
Depreciation & Amortization 18.18 Million 19.32 Million 20.38 Million 20.97 Million 25.57 Million 23.48 Million
Deferred income taxes - - - - - -
Stock-based compensation - - - - - -
Change in working capital -42.01 Million 17.59 Million -12.31 Million -5.7 Million 51.63 Million 23.76 Million
Other non-cash items 59.1 Million -8.22 Million 23.04 Million -6.45 Million -2.19 Million -16.93 Million
Investing Cash Flow -38.67 Million -19.77 Million -64.79 Million -14.87 Million -23.41 Million -51.89 Million
Investments in PPE -14.31 Million -16.6 Million -26.75 Million -20.68 Million -24.1 Million -52.3 Million
Acquisitions 6607.00 90.32 Thousand -35.08 Million 7.9 Million - -
Investment purchases - -1.5 Million - -180.99 Thousand - -9034.65
Sales/Maturities of investments 3.4 Million 37.63 Thousand 41.07 Thousand 1.3 Million 5 Million -
Other Investing Activities -27.77 Million -1.79 Million -2.99 Million -3.22 Million -4.31 Million 415.59 Thousand
Financing Cash Flow -37.38 Million -52.61 Million -66.77 Million -79.2 Million -94.23 Million -86.04 Million
Debt repayment - - - - -231.57 Thousand -
Dividends payments -37.37 Million -42.52 Million -46.94 Million -52.58 Million -54.61 Million -6 Billion
Common Stock Repurchased - -10.08 Million -19.83 Million -26.6 Million -39.38 Million -31.82 Million
Common Stock Issuance - - - - -2.00 -
Other Financing Activities -1 Million -7527.00 -8215.00 -9050.00 - -1.00
Accounts receivables -30.12 Million 7.31 Million 3.22 Million 11.32 Million 79.09 Million 26.87 Million
Accounts payables 5.81 Million 2.1 Million -21.6 Million -1.01 Million -33.12 Million -10.77 Million
Inventory -10.59 Million -4.38 Million 1.97 Million -26.45 Million 13.39 Million 26.47 Million
Other working capital -7.11 Million 12.56 Million 4.09 Million 10.44 Million -7.73 Million -18.81 Million
Cash at beginning of period 558.95 Million 613.03 Million 699.59 Million 679.18 Million 529.02 Million 495.47 Million
Cash at end of period 431.59 Million 558.95 Million 613.03 Million 699.59 Million 679.18 Million 529.02 Million
Capital Expenditure -14.31 Million -16.6 Million -26.75 Million -20.68 Million -24.1 Million -52.3 Million
Effect of forex changes on cash - - -64.53 Million -0.64 -0.68 -0.19
Net cash flow / Change in cash -127.35 Million -54.08 Million -86.55 Million 20.41 Million 150.15 Million 33.54 Million
Free Cash Flow 2.7 Million 53.04 Million 82.79 Million 109.44 Million 230.33 Million 138.59 Million

Cash Flow Charts